Free Trial

Analysts Set Acadia Healthcare Company, Inc. (NASDAQ:ACHC) PT at $44.75

Acadia Healthcare logo with Medical background

Key Points

  • Acadia Healthcare has been assigned an average rating of "Moderate Buy" by twelve brokerages, with a price target ranging from $29 to $45 and an average target of $44.75.
  • The company reported earnings of $0.83 per share for the latest quarter, surpassing expectations, with a revenue of $869.23 million, marking a 9.2% year-over-year increase.
  • Institutional investment in Acadia Healthcare is increasing, with significant stakes being raised by several hedge funds during the fourth quarter, reflecting growing confidence in the company's potential.
  • Five stocks we like better than Acadia Healthcare.

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the twelve brokerages that are presently covering the stock, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $43.25.

ACHC has been the subject of several analyst reports. Stephens upgraded Acadia Healthcare to a "hold" rating in a report on Monday, June 2nd. UBS Group dropped their price objective on Acadia Healthcare from $45.00 to $31.00 and set a "buy" rating on the stock in a research report on Thursday, August 7th. Royal Bank Of Canada dropped their price objective on Acadia Healthcare from $43.00 to $28.00 and set an "outperform" rating on the stock in a research report on Wednesday. KeyCorp dropped their price objective on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 14th. Finally, Cowen reaffirmed a "buy" rating on shares of Acadia Healthcare in a research report on Thursday, August 7th.

Get Our Latest Analysis on ACHC

Acadia Healthcare Stock Up 1.3%

ACHC traded up $0.27 during trading on Friday, reaching $20.60. The stock had a trading volume of 728,938 shares, compared to its average volume of 2,190,983. Acadia Healthcare has a one year low of $17.13 and a one year high of $82.40. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.73. The stock's 50 day moving average is $22.08 and its two-hundred day moving average is $27.42. The company has a market capitalization of $1.90 billion, a price-to-earnings ratio of 13.71, a P/E/G ratio of 3.71 and a beta of 0.88.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.83 earnings per share for the quarter, beating the consensus estimate of $0.71 by $0.12. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%. The firm had revenue of $869.23 million during the quarter, compared to the consensus estimate of $839.59 million. During the same period last year, the company earned $0.91 earnings per share. The company's revenue was up 9.2% on a year-over-year basis. As a group, analysts expect that Acadia Healthcare will post 3.38 earnings per share for the current year.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Caitong International Asset Management Co. Ltd lifted its position in shares of Acadia Healthcare by 11,218.2% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company's stock valued at $38,000 after buying an additional 1,234 shares in the last quarter. Quadrant Capital Group LLC lifted its position in shares of Acadia Healthcare by 287.1% during the 4th quarter. Quadrant Capital Group LLC now owns 1,258 shares of the company's stock valued at $50,000 after buying an additional 933 shares in the last quarter. UMB Bank n.a. raised its stake in Acadia Healthcare by 149.5% during the 1st quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock valued at $38,000 after purchasing an additional 755 shares during the period. Allworth Financial LP raised its stake in Acadia Healthcare by 676.4% during the 2nd quarter. Allworth Financial LP now owns 1,351 shares of the company's stock valued at $31,000 after purchasing an additional 1,177 shares during the period. Finally, State of Wyoming bought a new stake in Acadia Healthcare during the 4th quarter valued at approximately $56,000.

About Acadia Healthcare

(Get Free Report)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Read More

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Should You Invest $1,000 in Acadia Healthcare Right Now?

Before you consider Acadia Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.

While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.